HNO Journal Impact Factor & Information

Publisher: Springer Verlag

Journal description

Die Zeitschrift HNO berichtet über aktuelle wissenschaftliche Ergebnisse aus Klinik und Forschung. Die Herausgeber sind bemüht bei der Auswahl der Beiträge auch die Interessen des in der Praxis tätigen HNO-Arztes zu berücksichtigen. Zugleich wird in diagnostischen und therapeutischen Fragen des Fachgebietes eine kontinuierliche Fortbildung vermittelt. Über wichtige Kongresse und Symposien wird zusammenfassend in kurzen Berichten informiert. Zur Publikation eingereichte Manuskripte müssen bei Untersuchungen an Probanden oder Patienten die Erklärung enthalten daß das Versuchsprotokoll von einer Ethikkomission begutachtet wurde und somit den ethischen Standards der Deklaration von Helsinki 1964 in der jeweils gültigen Fassung (Pharm. Ind. Nr. 12/1990 sowie Bundesanzeiger Nr. 243a vom 29.12.1989) entspricht. Gleichzeitig ist die Einwilligung der Versuchsperson nach Aufklärung im Text des Manuskriptes zu fixieren. Hinweise die auf die Identität der Versuchsperson schließen lassen sind zu vermeiden. Tierversuchsprogramme müssen den Passus enthalten daß die "Principles of laboratory animal care" (NIH publication No. 86-23 revised 1985) eingehalten wurden soweit nicht zusätzlich besondere nationale Regelungen zu beachten sind (für die Bundesrepublik Deutschland ist dies das Tierschutzgesetz in aktueller Fassung). Die Herausgeber behalten sich deshalb das Recht vor Manuskripte abzulehnen die den o.g. Anforderungen nicht entsprechen. Der Autor haftet bei Verstoß gegen die o.g. Anforderungen oder bei falschen Angaben.

Current impact factor: 0.54

Impact Factor Rankings

2015 Impact Factor Available summer 2015
2013 / 2014 Impact Factor 0.538
2012 Impact Factor 0.42
2011 Impact Factor 0.4
2010 Impact Factor 0.543
2009 Impact Factor 0.464
2008 Impact Factor 0.57
2007 Impact Factor 0.653
2006 Impact Factor 0.533
2005 Impact Factor 0.484
2004 Impact Factor 0.514
2003 Impact Factor 0.473
2002 Impact Factor 0.507
2001 Impact Factor 0.62
2000 Impact Factor 0.722
1999 Impact Factor 0.486
1998 Impact Factor 0.675
1997 Impact Factor 0.621

Impact factor over time

Impact factor
Year

Additional details

5-year impact 0.45
Cited half-life 8.10
Immediacy index 0.13
Eigenfactor 0.00
Article influence 0.09
Website HNO website
Other titles HNO (Online), Hals- Nasen- Ohrenheilkunde
ISSN 1433-0458
OCLC 42964434
Material type Document, Periodical, Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publisher details

Springer Verlag

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Author's pre-print on pre-print servers such as arXiv.org
    • Author's post-print on author's personal website immediately
    • Author's post-print on any open access repository after 12 months after publication
    • Publisher's version/PDF cannot be used
    • Published source must be acknowledged
    • Must link to publisher version
    • Set phrase to accompany link to published version (see policy)
    • Articles in some journals can be made Open Access on payment of additional charge
  • Classification
    ​ green

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: The APD guideline of 2009 was supplemented by the statements listed here. The addition is based on current knowledge and findings. Otherwise, the Guideline 2009 remains valid. Here, a summary of the updated APD guideline is given, thus proving an overview of the definition of APD, diagnosis, differential diagnosis and recommended for APD management.
    HNO 06/2015; DOI:10.1007/s00106-015-0002-0
  • [Show abstract] [Hide abstract]
    ABSTRACT: The second part of this continuing medical education article focuses on sonographic assessment of the salivary glands, cervical paraganglioma, angioma, esophagus, extra cranial blood vessels and the temporomandibular joint. The currently available minimally invasive therapeutic options (e. g. sialendoscopy, lithotripsy, therapeutic duct lavage and extracapsular dissection) for salivary gland disease presuppose a precise imaging modality. Modern ultrasound is able to meet this challenge, making additional imaging a rare necessity. Regions of the neck with a difficult topography (esophagus and hypopharynx) can often be successfully portrayed sonographically. Furthermore, ultrasound enables functional evaluation of swallowing in the cervical parts of the esophagus in dysphagia patients. In addition to the branchial cleft anomalies and lymph nodes discussed in part 1, paraganglioma, angiomatosis and neurogenic tumors are important differential diagnoses of solid lesions of the neck. Finally, venous and arterial alterations of the extracranial vessels of the neck relevant to clinical routine are depicted, as are pathological conditions of the temporomandibular joint relevant to the otorhinolaryngologist.
    HNO 06/2015; DOI:10.1007/s00106-015-0010-0
  • [Show abstract] [Hide abstract]
    ABSTRACT: Classification of diseases on the molecular level is the basis for personalized medicine. Personalized medicine proposes to improve efficiency and quality of care, to reduce side effects and to increase long-term cost-effectiveness. This paper is concerned with the role of genetic diagnostics in patients with a cochlear implant. A selective literature search in PubMed was performed. Genetic diagnosis allows ruling out syndromic hearing loss and thus prevents follow-up studies. It allows genetic counseling, prognosis and advice on family planning and targeted prevention. Due to its minimal invasiveness, it is suitable for evaluation of factors accounting for hearing loss in children. Molecular medicine plays a major role in the treatment of sensorineural hearings loss with cochlear implants.
    HNO 06/2015; DOI:10.1007/s00106-015-0013-x
  • HNO 06/2015; DOI:10.1007/s00106-015-0025-6
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hearing aids (HA) provide adequate support for many patients with hearing loss, but not all. Around one third of 10.000 patients provided with hearing aids in the Abbreviated Profile of Hearing Aid Benefit felt no actual benefit when using the hearing aid, although they demonstrated the necessary hearing improvement on speech audiometry. Epidemiological data show bad compliance, especially in older people. Only one in three hearing aid owners wears their device regularly. For this subpopulation of patients active middle ear implants (AMEIs) have been used since 1998. In the present review, the current indications for AMEIs are presented. A selective literature search in PubMed, as well as a guideline search at the Arbeitsgemeinschaft der Wissenschaftlichen Fachgesellschaften e. V. (German Association of Scientific Societies), was carried out. The present review shows that when there is an adequate indication the hearing capacity of patients can be thoroughly rehabilitated and thus their quality of life improved with the help of AMEIs. Although most commercially available systems have a satisfactory risk profile, increased extrusion rates, malfunctioning and facial paresis have been reported in older implant series. The advantages of AMEIs include increased hearing gain, reduced feedback, increased hearing quality, increased speech discrimination in the presence of background noise, and an absence of occlusion. The audiological indication for AMEIs in primary care is usually controversial, since the functional hearing gain and increase in speech discrimination may be small compared with modern conventional hearing aids. AMEIs thus play a main role in the secondary care of patients who do not have sufficient benefit or who have side effects after having a conventional hearing aid fitted.
    HNO 06/2015; DOI:10.1007/s00106-015-0018-5
  • HNO 06/2015; DOI:10.1007/s00106-015-0019-4
  • [Show abstract] [Hide abstract]
    ABSTRACT: Individualisierte, personalisierte oder stratifizierte Ansätze in der Medizin eröffnen neue Möglichkeiten in der Allergologie und der HNO. Die Vermeidung von Nebenwirkungen, gezielte Therapieansätze und stratifizierte Prävention versprechen besseres therapeutisches Ansprechen und optimale Resultate für unsere Patienten. Begriffliche und definitorische Unschärfen bleiben, vor allem im Hinblick auf die Personalisierung. Auch sind ernsthafte medizinethische Bedenken zu berücksichtigen. Die Entwicklung der Pharmakogenomik, der molekularen Charakterisierung, der genetischen Sequenzierung und weiterer -omics öffnen die Tür zu einzigartigen mechanistischen therapeutischen Möglichkeiten. Bereits erhältliche molekulare und rekombinante allergologische Diagnostik ermöglicht eine deutliche Verbesserung der diagnostischen Genauigkeit, vor allem bei Anaphylaxien und Lebensmittelallergien. Um stratifizierte therapeutische Ansätze umsetzen zu können, müssen allerdings regulatorische Rahmenbedingungen mit der biomedizinischen Entwicklung mithalten. Abstract Individualized, personalized or stratified medicine approaches offer emerging opportunities in the field of allergy and ENT. Avoidance of side effects, targeted therapy approaches and stratified prevention promise better outcomes and optimal results for patients. Conceptual incongruencies remain with regard to definitions and perceptions of “personalized medicine”. Serious ethical considerations have to be taken into account. The development of pharmacogenomics, molecular phenotyping, genomic sequencing and other -omics opens the door to unique mechanistic therapeutic advances. The molecular allergology and recombinant diagnostics available are tools that offer substantial improved diagnostics for the benefit of allergic patients, e. g. in anaphylaxis and food allergy. For stratified therapeutic approaches, however, regulatory affairs will have to keep pace with medical and scientific discovery.
    HNO 05/2015; DOI:10.1007/s00106-015-0004-y
  • [Show abstract] [Hide abstract]
    ABSTRACT: Allergic diseases are among the most common diseases of humans. The immune response towards allergens is regulated by T-lymphozytes and characterized by an interleukin (IL)-4, IL-5 and IL-13 dominated Th2 cytokine profile. Allergen-specific immunotherapy (AIT) is the only causative treatment option and able to change the course of disease, e. g. to prevent the development of asthma and new sensitizations. The intralymphatic delivery of allergenes named intralymphatic immunotherapy (ILIT) has been evaluated in clinical trials and was demonstrated to be a highly potent application route with low effort and side effects while having equal efficacy if compared with current standard AIT forms. However, studies that verify important questions like optimal dose, new allergen forms, use of adjuvants etc. are still missing. Moreover, it has to be evaluated, whether different indications like rhinitis, or atopic dermatitis are suitable for ILIT and whether it is useful in children. Epicutaneous immunotherapy (EPIT) is a possible alternative application form. It is minimally invasive and basically consists of the affixation of allergen containing patches to the epidermis over 6 weeks. From the studies performed so far, the authors concluded, that epicutaneous immunotherapy is safe and efficacious in a dose-dependent manner after 6 patches only. AIT is accepted to be the only causative treatment option for allergies. New application routes in ILIT and EPIT may become more important and allow for different delivery methods in the future, however further clinical studies are required and in preparation.
    HNO 05/2015; DOI:10.1007/s00106-015-0003-z
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die heute als „lokale allergische Rhinitis“ (LAR) bezeichnete Sonderform der allergischen Rhinitis (AR) ist durch eine (ausschließlich) lokale, direkt in der Nasenschleimhaut stattfindende IgE-Produktion (spezifische Immunglobuline vom Typ E (sIgE) charakterisiert. Der Nachweis von IgE mit den üblichen Allergietestverfahren im Serum oder in Hauttestungen ist jedoch nicht möglich, weshalb bei diesen Patienten in der Vergangenheit häufig eine nichtallergische Rhinitis diagnostiziert wurde. Die Diagnose der LAR wird durch klinische Symptome, den lokalen Nachweis von sIgE im Nasensekret und/oder eine positive nasale Allergenprovokationstestung gestellt. Erste diagnostische Schritte beinhalten die ausführliche Anamnese, einen Hauttest und die In-vitro-Diagnostik aus dem Serum. Bei passender Anamnese sollte darauf die Quantifizierung des nasalen spezifischen IgE und der nasalen Provokationstests mit in Frage kommenden Allergenen folgen. Wir berichten über zwei Fälle einer LAR auf Alternaria alternata mit persistierenden Symptomen einer allergischen Rhinitis, die durch nasale Provokationstestungen und Nachweis von spezifischen IgE-Antikörpern auf Alternaria alternata im Nasensekret diagnostiziert wurden. Dies sind gemäß aktueller Literaturrecherche die weltweit zweiten Fallbeschreibungen einer LAR auf Alternaria alternata. Abstract In a subgroup of patients with symptoms of allergic rhinitis (AR), no systemic sensitization can be detected in skin tests or serum. These patients are considered to be afflicted with so-called “local allergic rhinitis” (LAR) with IgE-production exclusively at the site of the nasal mucosa. Patients without any positive allergy test results but seasonal (intermittent) or perennial (persistent) allergic symptoms were often misdiagnosed as having “non-allergic rhinitis” (NAR) in the past. However, there is evidence for a specific IgE-production in the nasal mucosa in these patients without systemic sensitization. The diagnosis of LAR is confirmed by clinical symptoms, the detection of specific IgE production in the nasal mucosa and/or nasal provocation tests. We report on two cases of LAR to Alternaria alternata with symptoms of persistent allergic rhinitis that have been diagnosed by positive allergenspecific nasal challenge tests and specific IgE determinations in nasal secretions. According to an actual literature research, this is the second report published on LAR caused by Alternaria alternata.
    HNO 05/2015; DOI:10.1007/s00106-015-0005-x
  • [Show abstract] [Hide abstract]
    ABSTRACT: A differential diagnosis of persistent chronic rhinosinusitis is ASA-intolerance syndrome (AIS), also known as Aspirin®‑exacerbated respiratory disease (AERD), Samter-Trias (Samter's disease, Morbus Widal). Particularly in cases of frequent recurrency of nasal polyps in combination with bronchial asthma and hypersensitivity reactions to acetylsalicylic acid (ASA) and other nonsteroidal anti-inflammatory drugs (NSAR) can often be referred to an underlying AIS. The pathogenesis of this syndrome is attributed to a misallocation of the arachidonic acid metabolism, resulting in an increased leukotriene production. The diagnosis may be difficult in the early stages of the disease with incomplete triad of symptoms. Therapy may consist of paranasal sinuses surgery, drug therapy and adaptive deactivation as the only causal treatment option for patients with AIS. For adaptive desactivation, positive effects were actually shown even in patients with long-term recurrent or persistent complaints of chronic rhinosinusitis.
    HNO 05/2015; DOI:10.1007/s00106-015-0008-7
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recent research has focused on the relationship between vitamin D and allergy development. Results show that on the one hand a vitamin D deficiency can be responsible for the emergence of allergies, however, on the other hand a vitamin-D (over-) substitution was also seen in context with an increased allergy development. This article provides an overview on the current state of research and points at the problematic aspects that accompany the assessment of these studies. The paradoxic effect of vitamin D is currently being explained by epigenetic programming in pregnancy, by too low vitamin-D levels or excessive supplementation in newborns. Very recently, a gender-specific impact of vitamin D is also being discussed. For a final assessment of vitamin-D effects on the emergence of allergies, further research is necessary. Due to a high level of heterogeneity among current observational studies regarding central aspects of the discussion, randomised clinical trials are recommended.
    HNO 05/2015; DOI:10.1007/s00106-015-0001-1
  • [Show abstract] [Hide abstract]
    ABSTRACT: Animal models of tinnitus complement human findings and potentially deepen our insight into the neural substrates of tinnitus. The fact that animal data are largely based on recordings from the auditory system, in particular from subcortical structures, makes comparison with human electrophysiological data from predominantly cortical areas difficult. Electro/magnetoencephalography and imaging data extend beyond the auditory cortex. The most challenging link to be made is the one between the macroscopic data in humans and the microscopic (single neuron action potentials) and mesoscopic (local field potentials) results obtained in animal models. Since invasive recordings in humans are rare, a bridge needs to be built on the basis of changes in brain rhythms in animals with putative tinnitus.
    HNO 04/2015; 63(4):298-301. DOI:10.1007/s00106-014-2980-8
  • [Show abstract] [Hide abstract]
    ABSTRACT: Most tinnitus studies have attempted to compare groups of individuals, thus revealing inter-individuals differences, i.e., variations between compared subjects. For methodological reasons, inter-individual studies cannot take into account the variability of tinnitus experience, which has been known for decades to be relevant in daily practice with tinnitus patients. The concept of intra-individual variability has been promoted in the research literature, in order to shed light on this aspect of individual perception. In previous studies, unrelated to hearing, the concept of intra-individual variability implied inclusion of the environment (i.e., physical and social interactions) as a factor of individual performance. In tinnitus research, we believe that the concept of variability (within a person) could find a place beside the concept of variation (between groups of subjects). In this paper, four perspectives of tinnitus experiences from the clinical and research fields are described: (1) ENT consultation; (2) short-term group psychotherapy; (3) psychodynamic psychotherapy; and (4) clinical psychological research. Intra-individual variability stresses the importance of defining tinnitus in a dynamic way, contrary to the current definition of tinnitus as the perception of sound(s). In clinical practice, it is useful to embrace the perspective of the perceiver of tinnitus, and to include social and cultural circumstances as well as audiological/physical changes.
    HNO 04/2015; 63(4):302-306. DOI:10.1007/s00106-014-2978-2
  • [Show abstract] [Hide abstract]
    ABSTRACT: This year marks 25 years of tinnitus retraining therapy (TRT), the approach that aims to eliminate tinnitus as a problem by extinguishing functional connections between the auditory and the limbic and autonomic nervous systems to achieve habituation of tinnitus-evoked reactions and subsequently habituation of perception. TRT addresses directly decreased sound tolerance (DST) as well as tinnitus. TRT consists of counseling and sound therapy, both based on the neurophysiological model of tinnitus. The main goal of retraining counseling is to reclassify tinnitus into the category of a neutral stimulus, while the main goal of sound therapy is to decrease the strength of tinnitus-related neuronal activity. A unique aspect of TRT is that because treatment is aimed to work above the tinnitus source, and at connections linking the auditory and other systems in the brain, the etiology of tinnitus is irrelevant. Any type of tinnitus, as well as somatosounds, can be successfully treated by TRT. Over 100 publications can be found on Medline when using "tinnitus retraining therapy" as a search term. The majority of these publications indicate TRT offers significant help for about 80 % of patients. A randomized clinical trial showing the effectiveness of TRT has been published and another large study is in progress. The principles of the neurophysiological model of tinnitus, and consequently TRT, have not changed in over 25 years of use, but a number of changes have been introduced in TRT implementation. These changes include the recognition of the importance of conditioned reflexes and the dominant role of the subconscious pathways; the introduction of the concept of misophonia (i.e., negative reactions to specific patterns of sound) and the implementation of specific protocols for its treatment; greater emphasis on the concurrent treatment of tinnitus, hyperacusis, misophonia, and hearing loss; extensive modification of counseling; and refinements in sound therapy. The effectiveness of TRT has increased significantly during the past 25 years, presumably due to changes incorporated in its implementation. The main improvement has been to shorten the average time until seeing clear improvement from 1 year to 1 month, with a statistically significant improvement seen at, and after, 3 months. Furthermore, there is a higher effectiveness and a shorter treatment time for DST and an increased extent of help for hearing loss.
    HNO 04/2015; 63(4):307-311. DOI:10.1007/s00106-014-2979-1
  • [Show abstract] [Hide abstract]
    ABSTRACT: The cochlear implant became a very successful method of hearing rehabilitation for patients with profound sensorineural hearing loss. The benefits of the CI extend beyond the medical success and positively influence social and psychosocial areas, reflected by an improved HRQoL. Furthermore, variety of studies demonstrated that the tinnitus severity improves in 46-95 % of cases following the cochlear implantation. However, the parameters investigated in such studies are not always standardized or addressed by validated questionnaires, which explains the high outcome variation between the studies. The relationships between HRQoL and tinnitus distress before and after cochlear implantation have not been well studied. Nevertheless, it is believed that the improvement in HRQoL following CI affects particularly tinnitus.However, an existing tinnitus can also worsen or occur for the first time after the surgery. Since neither tinnitus frequency nor tinnitus loudness correlate with the tinnitus-induced distress, the measurement of HRQoL, distress factors, stress reactions and psychiatric comorbidities appears to be the meaningful assessment of positive or negative effects of CI on tinnitus.Initial studies demonstrated that also patients with unilateral hearing loss may benefit from CI supply, as shown by an improvement in HRQoL and reduction of tinnitus-induced distress. For those patients, who despite CI implantation experience severe tinnitus, there is an option of tinnitus-specific CI-fitting and tinnitus-specific therapy with psychosomatic and psychological approaches, and- in addition- a treatment of possible mental comorbidities.
    HNO 04/2015; 63(4):291-7. DOI:10.1007/s00106-014-2975-5
  • [Show abstract] [Hide abstract]
    ABSTRACT: Tinnitus can be caused or triggered by funtional disorders of the cervical spine, temporomandibular joint or any other musculoskeletal structure of the neck or head. This special form of tinnitus is called somatosensory tinnitus and represents a discrete subgroup among the different kinds of tinnitus. Distinctive for this kind of tinnitus are alterations in volume and frequency during movement or the stimulation of certain muscles and joints. This can be evaluated using a structured testing method. To be able to easily perceive tinnitus modulations, the test must be performed in total silence. Effective treatment modules are physiotherapy, osteopathy, neural therapy, and Qigong for self-help.
    HNO 04/2015; 63(4):266-71. DOI:10.1007/s00106-014-2971-9